Macmillan Research Advisory Panel

Read more about the current members of our Research Advisory Panel below.

Dr Stephen Barclay

Stephen Barclay is University Senior Lecturer in Palliative Care and General Practice at the University of Cambridge. His clinical medical work in general practice and hospice inform his research interests which are in palliative and end of life care, particularly in the community and general practice settings. He also leads medical student teaching in palliative care in Cambridge and has a research interest in medical education in palliative care. He leads the Cambridge Palliative and End of Life Care Group which includes doctors, nurses, psychologists, statisticians, and social scientists and uses a range of research methods: qualitative, quantitative, mixed methods and systematic literature reviews.

Professor Diana Greenfield

Diana Greenfield is a registered nurse with a PhD (using quantitative methods). She is dual qualified in oncology and endocrinology and has further qualifications in education and advanced practice. She is also Honorary Professor in Cancer Survivorship in the Department of Oncology and Metabolism, University of Sheffield.  Her clinical expertise is in late effects anticipatory care for those who have had a stem cell transplant, haematological and younger adults with solid tumours, adolescent and childhood cancer survivors, including transitional care of childhood cancer survivors into adult services. Across cancer services she promotes recovery and optimising health and well-being after cancer by leading the improvement of aftercare services for cancer patients locally, regionally and influencing nationally. Her principal academic interests are: the physical and psychological late treatment consequences in survivors of cancer treatment, including metabolic syndrome; return to work and physical activity after cancer; models of follow-up and care after cancer treatment; cancer care workforce competences.

Dr Yoryos (Georgios) Lyratzopoulos

Yoryos is Reader in Cancer Epidemiology at University College London (UCL) and Cancer Research UK Advanced Clinician Scientist Fellow. He is also part-time affiliated to the University of Cambridge and Public Health England's National Cancer Registration and Analysis Service. His research focuses on the predictors and outcomes of diagnostic timeliness in cancer patients; and cancer patient experience. He was previously NIHR Post-Doctoral Fellow (2012-14) and has worked for the English NHS and NICE as a hospital doctor and public health physician. To December 2016, he has published about 130 peer-reviewed papers, two thirds of which as first/last author. Yoryos holds the Cancer Research UK Future Leaders Prize in Cancer Research (2016), which recognises individuals who have demonstrated the potential to achieve world-leading status by producing research of international importance within their first 10 post-doctoral years.

Professor Henrik Møller

Henrik Møller is Professor of Cancer Epidemiology at King’s College London, and Director of Cancer Epidemiology and Population Health in King’s Health Partners Comprehensive Cancer Centre. He holds an honorary academic contract with Public Health England, and has academic associations with several medical schools at universities in England and Denmark. Henrik's research focuses on variation in health care provision and associated patient outcomes. In an international research career spanning more than three decades, he has published 350+ peer reviewed research articles in cancer epidemiology and health services research.

Professor Tim Peters

Tim Peters is Professor of Primary Care Health Services Research and Head of the School of Clinical Sciences at the University of Bristol, where he is also Research Director for the Faculty of Health Sciences. A statistician and trialist with over 30 years’ experience of epidemiology and research on health and health services, mostly in primary care. His research interests focus on community-based evaluations of health interventions. Many of these evaluations involve randomised trials conducted by multidisciplinary research teams including quantitative and qualitative methodologists. Tim has also conducted research on the methodology of trials, especially where groups of individuals are randomised (cluster trials) or there is interest in exploring the extent to which interventions confer greater benefit to some individuals than to others (subgroup analyses). A further priority has been the development and supervision of researchers from a variety of backgrounds – 20 doctoral degrees undertaken by doctors, nurses, other health care professionals and research methodologists.

Professor Peter Smith

Peter C. Smith is Emeritus Professor of Health Policy at Imperial College Business School. Smith is a mathematics graduate from the University of Oxford, and started his academic career in the Public Health department at the University of Cambridge. His main research has been in the economics of health and public finance, and he was a previous Director of the Centre for Health Economics at the University of York. Smith has acted in numerous UK governmental advisory capacities, and is currently chair of the NHS Advisory Committee on Resource Allocation. He has also advised many overseas governments and international agencies, including the World Health Organisation, the International Monetary Fund, the World Bank, the European Commission and the Organisation for Economic Cooperation and Development. He continues to research actively on economic aspects of health systems and global health, including the economics of cancer care.

Professor Mary Wells

Mary is a cancer nurse with a clinical academic background in health services research within oncology. Her research is mainly focused on the supportive care of people with cancer and in particular the needs, experiences and outcomes of people who have completed treatment. She also has methodological expertise in qualitative research and the development and evaluation of complex interventions. Mary works closely with a number of cancer charities with a major interest in improving experiences, outcomes and cancer care practice. She was a member of the Executive Board of the European Oncology Nursing Society (EONS) from 2009 – 2015 (and Secretary from 2011-2015) and she is currently co-chair of the EONS Research Working Group. Since 2009 she has been a specialist advisor to Macmillan Cancer Support and the Consequences of Cancer Treatment Collaborative, and she is on the Clinical Advisory Board of the Throat Cancer Foundation. In 2016 Mary was appointed as a trustee of HealthTalk (previously DiPeX). She has been a member of the NCRI Psychosocial Oncology and Survivorship Clinical Studies Group (CSG) since 2013 and has led the interventions sub-group since 2015. She is also a member of the survivorship sub-group of the Head and Neck CSG. Mary has extensive grant reviewing experience for a range of bodies, including the NIHR, Cancer Research UK, the Chief Scientist Office, and NHS R&D boards. She reviews for numerous journals and is an Associate Editor of the European Journal of Oncology Nursing.